PLAY PODCASTS
How Abbott and Cordis are working to change the interventional vascular business

How Abbott and Cordis are working to change the interventional vascular business

Let's get interventional. This week, we talk with leaders from Abbott and Cordis about their plans to advance of medtech's stablest business. Duke Rohlen, executive chair, will explain to co-host Tom Salemi why he led the purchase of Cordis from Cardinal. Meanwhile, Dr. Nick West, CMO and DVP of vascular at Abbott, updates Associated Editor Sean Whooley on the Xience pipeline. This week's Newmarker's Newsmakers brings the big news from Abbott, Heartflow, Intersect ENT, Intuitive, Medtronic, Philips, and Resmed. Subscribe to this podcast on all major podcast applications!

DeviceTalks Podcast Network · DeviceTalks Podcast Network

August 13, 20211h 3m

Audio is streamed directly from the publisher (episodes.castos.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Original episode page

Show Notes

Let's get interventional. This week, we talk with leaders from Abbott and Cordis about their plans to advance of medtech's stablest business. Duke Rohlen, executive chair, will explain to co-host Tom Salemi why he led the purchase of Cordis from Cardinal. Meanwhile, Dr. Nick West, CMO and DVP of vascular at Abbott, updates Associated Editor Sean Whooley on the Xience pipeline. This week's Newmarker's Newsmakers brings the big news from Abbott, Heartflow, Intersect ENT, Intuitive, Medtronic, Philips, and Resmed. Subscribe to this podcast on all major podcast applications!

Topics

MassDevicemedicaltechnologyindustrymedicaldeviceindustrymedtech
← All episodes of DeviceTalks Podcast Network